Quick Answer
NovoCure Ltd reported Common Stock Shares Outstanding of 112.49 million shares for the year ending 2025.
- NovoCure Ltd showed an increase of +3.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from NovoCure Ltd's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), NovoCure Ltd's Common Stock Shares Outstanding has grown by 737.5%.
- Historical annual values: Fiscal year 2025: 112.49 million shares | Fiscal year 2024: 108.52 million shares | Fiscal year 2023: 107.08 million shares | Fiscal year 2022: 105.05 million shares | Fiscal year 2021: 103.97 million shares | Fiscal year 2020: 102.33 million shares | Fiscal year 2019: 99.53 million shares | Fiscal year 2018: 93.25 million shares | Fiscal year 2017: 89.48 million shares | Fiscal year 2016: 87.07 million shares | Fiscal year 2015: 83.78 million shares | Fiscal year 2014: 13.43 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: